185 related articles for article (PubMed ID: 19712046)
1. Expression of versican isoform V3 in the absence of ascorbate improves elastogenesis in engineered vascular constructs.
Keire PA; L'Heureux N; Vernon RB; Merrilees MJ; Starcher B; Okon E; Dusserre N; McAllister TN; Wight TN
Tissue Eng Part A; 2010 Feb; 16(2):501-12. PubMed ID: 19712046
[TBL] [Abstract][Full Text] [Related]
2. Use of versican variant V3 and versican antisense expression to engineer cultured human skin containing increased content of insoluble elastin.
Merrilees MJ; Falk BA; Zuo N; Dickinson ME; May BC; Wight TN
J Tissue Eng Regen Med; 2017 Jan; 11(1):295-305. PubMed ID: 24945362
[TBL] [Abstract][Full Text] [Related]
3. Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury.
Merrilees MJ; Lemire JM; Fischer JW; Kinsella MG; Braun KR; Clowes AW; Wight TN
Circ Res; 2002 Mar; 90(4):481-7. PubMed ID: 11884379
[TBL] [Abstract][Full Text] [Related]
4. Retrovirally mediated overexpression of glycosaminoglycan-deficient biglycan in arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointimae after vascular injury.
Hwang JY; Johnson PY; Braun KR; Hinek A; Fischer JW; O'Brien KD; Starcher B; Clowes AW; Merrilees MJ; Wight TN
Am J Pathol; 2008 Dec; 173(6):1919-28. PubMed ID: 18988796
[TBL] [Abstract][Full Text] [Related]
5. Hydrostatic pressure independently increases elastin and collagen co-expression in small-diameter engineered arterial constructs.
Crapo PM; Wang Y
J Biomed Mater Res A; 2011 Mar; 96(4):673-81. PubMed ID: 21268239
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin promotes elastin deposition, elasticity and mechanical strength in cellularised collagen-based scaffolds.
Pezzoli D; Di Paolo J; Kumra H; Fois G; Candiani G; Reinhardt DP; Mantovani D
Biomaterials; 2018 Oct; 180():130-142. PubMed ID: 30036726
[TBL] [Abstract][Full Text] [Related]
7. Induced elastic matrix deposition within three-dimensional collagen scaffolds.
Venkataraman L; Ramamurthi A
Tissue Eng Part A; 2011 Nov; 17(21-22):2879-89. PubMed ID: 21702719
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional topography of synthetic scaffolds induces elastin synthesis by human coronary artery smooth muscle cells.
Lin S; Sandig M; Mequanint K
Tissue Eng Part A; 2011 Jun; 17(11-12):1561-71. PubMed ID: 21284555
[TBL] [Abstract][Full Text] [Related]
9. A novel single-step self-assembly approach for the fabrication of tissue-engineered vascular constructs.
Gauvin R; Ahsan T; Larouche D; Lévesque P; Dubé J; Auger FA; Nerem RM; Germain L
Tissue Eng Part A; 2010 May; 16(5):1737-47. PubMed ID: 20038201
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of intact elastin scaffolds in tissue-engineered collagen-based vascular grafts.
Berglund JD; Nerem RM; Sambanis A
Tissue Eng; 2004; 10(9-10):1526-35. PubMed ID: 15588412
[TBL] [Abstract][Full Text] [Related]
11. Physiologic compliance in engineered small-diameter arterial constructs based on an elastomeric substrate.
Crapo PM; Wang Y
Biomaterials; 2010 Mar; 31(7):1626-35. PubMed ID: 19962188
[TBL] [Abstract][Full Text] [Related]
12. Elastic fiber production in cardiovascular tissue-equivalents.
Long JL; Tranquillo RT
Matrix Biol; 2003 Jun; 22(4):339-50. PubMed ID: 12935818
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of elastin and collagen leads to highly compliant engineered blood vessels.
Gao J; Crapo P; Nerem R; Wang Y
J Biomed Mater Res A; 2008 Jun; 85(4):1120-8. PubMed ID: 18412137
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury.
Huang R; Merrilees MJ; Braun K; Beaumont B; Lemire J; Clowes AW; Hinek A; Wight TN
Circ Res; 2006 Feb; 98(3):370-7. PubMed ID: 16385080
[TBL] [Abstract][Full Text] [Related]
15. A dynamically cultured collagen/cells-incorporated elastic scaffold for small-diameter vascular grafts.
Park IS; Kim YH; Jung Y; Kim SH; Kim SH
J Biomater Sci Polym Ed; 2012; 23(14):1807-20. PubMed ID: 21943800
[TBL] [Abstract][Full Text] [Related]
16. Elastin biosynthesis: The missing link in tissue-engineered blood vessels.
Patel A; Fine B; Sandig M; Mequanint K
Cardiovasc Res; 2006 Jul; 71(1):40-9. PubMed ID: 16566911
[TBL] [Abstract][Full Text] [Related]
17. Neointima formed by arterial smooth muscle cells expressing versican variant V3 is resistant to lipid and macrophage accumulation.
Merrilees MJ; Beaumont BW; Braun KR; Thomas AC; Kang I; Hinek A; Passi A; Wight TN
Arterioscler Thromb Vasc Biol; 2011 Jun; 31(6):1309-16. PubMed ID: 21441139
[TBL] [Abstract][Full Text] [Related]
18. Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion.
Kang I; Yoon DW; Braun KR; Wight TN
J Biol Chem; 2014 May; 289(22):15393-404. PubMed ID: 24719328
[TBL] [Abstract][Full Text] [Related]
19. Manipulation of remodeling pathways to enhance the mechanical properties of a tissue engineered blood vessel.
Ogle BM; Mooradian DL
J Biomech Eng; 2002 Dec; 124(6):724-33. PubMed ID: 12596641
[TBL] [Abstract][Full Text] [Related]
20. In vitro elastogenesis: instructing human vascular smooth muscle cells to generate an elastic fiber-containing extracellular matrix scaffold.
Hinderer S; Shena N; Ringuette LJ; Hansmann J; Reinhardt DP; Brucker SY; Davis EC; Schenke-Layland K
Biomed Mater; 2015 Mar; 10(3):034102. PubMed ID: 25784676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
